Allo GDA-201 Natural Killer (NK) Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allo GDA-201 Natural Killer (NK) Cells, covering 2025-03-25 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL [Phase 1, Phase 2]